These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1882866)

  • 1. Working toward uniformity in evaluation of ADR-reporting programs.
    Woodson HA
    Am J Hosp Pharm; 1991 Jul; 48(7):1428. PubMed ID: 1882866
    [No Abstract]   [Full Text] [Related]  

  • 2. Reporting drug product defects--JCAHO.
    Hoffmann RP
    Hosp Pharm; 1989 Feb; 24(2):143-4. PubMed ID: 10318199
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse drug reaction reporting--proposal to implement a revised system.
    Linkewich JA
    Hosp Pharm; 1989 Feb; 24(2):122-4. PubMed ID: 10292192
    [No Abstract]   [Full Text] [Related]  

  • 4. Revised ADR report permits internal review of drug experience.
    Jeffrey LP
    Pharm Times; 1986 Dec; 52(12):48-50. PubMed ID: 10317827
    [No Abstract]   [Full Text] [Related]  

  • 5. Review of Canadian pharmacist involvement in adverse drug reaction reporting.
    Taras-Zasowski KM; Einarson TR
    Can J Hosp Pharm; 1989 Jun; 42(3):105-8, 133. PubMed ID: 10318271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JCAHO's pharmaceutical care plan requirements.
    Rich DS
    Hosp Pharm; 1995 Apr; 30(4):315-9. PubMed ID: 10141874
    [No Abstract]   [Full Text] [Related]  

  • 7. Hospital pharmacy compliance with JCAHO standards and ASHP guidelines for reporting adverse drug reactions.
    Tyler LS; Nickman NA
    Am J Hosp Pharm; 1992 Apr; 49(4):845-50. PubMed ID: 1595720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality assurance to quality improvement: measuring and monitoring pharmaceutical care.
    Angaran DM
    Am J Hosp Pharm; 1991 Sep; 48(9):1901-7. PubMed ID: 1928130
    [No Abstract]   [Full Text] [Related]  

  • 9. Understanding JCAH and preparing the pharmacy.
    Coe CP; Louviere ML
    Am J Hosp Pharm; 1986 Oct; 43(10):2407-11. PubMed ID: 3466537
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacy-related standards in the 1994 AMH; drug samples; and adverse drug reaction requirements.
    Rich DS
    Hosp Pharm; 1994 Jan; 29(1):73-5. PubMed ID: 10171780
    [No Abstract]   [Full Text] [Related]  

  • 11. Quality assurance through adverse drug reaction reporting: improving hypnotic prescribing.
    Phillips MS
    Hosp Pharm; 1990 Mar; 25(3):246-8. PubMed ID: 10170509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concerns with postmarketing surveillance.
    Norvell MJ; Anderson RJ
    Am J Hosp Pharm; 1984 Jan; 41(1):54, 56. PubMed ID: 6695933
    [No Abstract]   [Full Text] [Related]  

  • 13. [International reporting of adverse drug reactions. Final report of CIOMS ADR Working Group].
    Royer RJ; Benichou C
    Therapie; 1991; 46(3):173-8. PubMed ID: 1792648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Draft guidelines on quality assurance for pharmacy-prepared sterile products.
    Am J Hosp Pharm; 1992 Feb; 49(2):407-17. PubMed ID: 1554008
    [No Abstract]   [Full Text] [Related]  

  • 15. The JCAHO Agenda for Change: what changes in pharmacy and P & T activities do you need to prepare for in 1994?
    Doherty EC
    Hosp Formul; 1994 Jan; 29(1):54-6, 58-60, 64 passim. PubMed ID: 10131267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-pharmaceutical JCAHO standards relating to pharmacy.
    Hoffmann RP
    Hosp Pharm; 1990 Mar; 25(3):279-81, 288. PubMed ID: 10103840
    [No Abstract]   [Full Text] [Related]  

  • 17. How to prepare for a 1995 JCAHO survey.
    Rich DS
    Hosp Pharm; 1995 Jan; 30(1):62-4. PubMed ID: 10139731
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse drug reaction reporting system: developing a well-monitored program.
    Kilarski DJ; Ziegler B; Coarse J; Buchanan C
    Hosp Formul; 1986 Sep; 21(9):949-52. PubMed ID: 10289704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved reporting of adverse drug reactions.
    Kimelblatt BJ; Young SH; Heywood PM; Mandala AR; Gendelman S; Mehl B
    Am J Hosp Pharm; 1988 May; 45(5):1086-9. PubMed ID: 3400650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A team approach to adverse drug reaction surveillance: success at a tertiary care hospital.
    Saltiel E; Johnson E; Shane R
    Hosp Formul; 1995 Apr; 30(4):226-8, 231-2. PubMed ID: 10141866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.